Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities Conference
Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities Conference
Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company's licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit and follow Biofrontera on LinkedIn and Twitter.WOBURN, MA / ACCESSWIRE / September 25, 2024 / Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatologic products, today announced that management will present at the 3rd Annual ROTH Healthcare Opportunities Conference to be held at the Metropolitan Club in New York, NY.
WOBURN, MA / ACCESSWIRE / 2024年9月25日 / Biofrontera Inc.(納斯達克: BFRI)是一家生物製藥公司，專門從事皮膚科產品的商業化，今天宣佈管理層將參加在紐約市大都會俱樂部舉行的第三屆ROTH醫療保健機遇大會。
Date: October 9, 2024
Time of Presentation: 12:30 - 1:10 PM ET
Format: Live Presentation
1x1 Meetings: Please contact your Roth representative
日期：2024年10月9日
演示時間：ET下午12:30-1:10
格式：現場演示
1對1會議：請聯繫您的Roth代表
About Biofrontera Inc.
Biofrontera公司簡介
Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company's licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit and follow Biofrontera on LinkedIn and Twitter.
Biofrontera Inc.是一家總部位於美國的生物製藥公司，商業化一系列針對皮膚疾病的藥品，重點是光動力療法（PDT）和局部抗生素。該公司的授權產品用於治療日光性角化症（前癌性皮膚病變）以及天皰瘡（一種細菌性皮膚感染）。欲了解更多信息，請訪問該鏈接，並關注Biofrontera在LinkedIn和Twitter上的動態。
Contacts Investor Relations
Andrew Barwicki
1-516-662-9461
ir@bfri.com
投資者關係聯繫人
安德魯·巴里基
1-516-662-9461
ir@bfri.com
SOURCE: Biofrontera Inc.
消息來源：Biofrontera Inc。
譯文內容由第三人軟體翻譯。
